Rocket Pharmaceuticals, Inc. (RCKT) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, the three largest insider holders of RCKT are Investments, Lp Rtw (Director, 18.19Mn shares), Roderick Wong (Director, 16.27Mn shares), Gaurav Shah (Ceo, 1.05Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Investments, Lp Rtw 0 18,188,457 23 Sep, 2025
Roderick Wong 0 16,272,635 31 Aug, 2021
Gaurav Shah Ceo 1,046,055 0 20 Feb, 2026
Martin Wilson General Counsel 682,000 0 20 Feb, 2026
Christopher James Stevens Chief Operating Officer 469,129 0 13 Feb, 2026
Kinnari Patel See Remarks 441,927 0 22 May, 2025
Gotham Makker 0 415,346 18 Jul, 2025
Syed Ali-Aamir Rizvi Chief Medical Officer 407,874 0 13 Feb, 2026
Jonathan David Schwartz See Remarks 299,064 0 20 Nov, 2025
Sarbani Chaudhuri See Remarks 285,160 0 13 Feb, 2026
Aaron Ondrey Chief Financial Officer 128,173 0 08 Jul, 2025
David P Southwell 0 113,124 20 May, 2024
John Militello See Remarks 91,019 0 20 Feb, 2026
Mark Andrew White See Remarks 69,140 0 04 Nov, 2024
Peter Fong 53,333 0 03 Oct, 2025
Elisabeth Bjork 50,000 0 06 Jan, 2026
Roderick Wong 47,667 0 18 Jul, 2025
Mikael Dolsten 44,220 0 18 Jul, 2025
David P Southwell 31,660 0 18 Jul, 2025
Fady Ibraham Malik 30,000 0 18 Jul, 2025
Carsten Boess 30,000 0 18 Jul, 2025
Piratip Pratumsuwan 30,000 0 18 Jul, 2025
Kinnari Patel See Remarks 0 26,774 10 Apr, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
18 Feb, 2026 John Militello Common Stock D 1,157 $3.34 91,019 D S
18 Feb, 2026 Gaurav Shah Common Stock D 5,990 $3.34 1,046,055 D S
18 Feb, 2026 Martin Wilson Common Stock D 1,376 $3.34 682,000 D S
13 Feb, 2026 John Militello Common Stock D 3,726 $3.31 92,176 D S
13 Feb, 2026 Gaurav Shah Common Stock D 12,279 $3.31 1,052,045 D S
13 Feb, 2026 Martin Wilson Common Stock D 12,253 $3.31 683,376 D S
11 Feb, 2026 Syed Ali-Aamir Rizvi Common Stock A 61,963 $0.00 407,874 D A
11 Feb, 2026 John Militello Common Stock A 29,982 $0.00 95,902 D A
11 Feb, 2026 Christopher James Stevens Common Stock A 61,963 $0.00 469,129 D A
11 Feb, 2026 Martin Wilson Common Stock A 311,813 $0.00 695,629 D A
11 Feb, 2026 Sarbani Chaudhuri Common Stock A 125,924 $0.00 285,160 D A
11 Feb, 2026 Gaurav Shah Common Stock A 286,028 $0.00 1,064,324 D A
11 Feb, 2026 Christopher James Stevens Stock Option (Right to Buy) A 93,037 $0.00 93,037 D A
11 Feb, 2026 Martin Wilson Stock Option (Right to Buy) A 468,187 $0.00 468,187 D A
11 Feb, 2026 Syed Ali-Aamir Rizvi Stock Option (right to buy) A 93,037 $0.00 93,037 D A
11 Feb, 2026 Sarbani Chaudhuri Stock Option (Right to Buy) A 189,076 $0.00 189,076 D A
11 Feb, 2026 John Militello Stock Option (Right to Buy) A 45,018 $0.00 45,018 D A
11 Feb, 2026 Gaurav Shah Stock Option (Right to Buy) A 870,648 $0.00 870,648 D A
02 Jan, 2026 Elisabeth Bjork Common Stock A 10,000 $3.44 50,000 D P
18 Nov, 2025 Gaurav Shah Common Stock D 6,276 $2.98 778,296 D S